Showing results (51-60 of 76) with videos related to
Sort By:
Pageof 8
Annals of the Rheumatic Diseases|December 12, 2025
A proteomic profile correlates with salivary gland inflammation and disease-associated antibodies in Sjögren's diseaseAlbin Björk, Johannes Mofors, Lauro Meneghel, et al.Science Translational Medicine|July 26, 2013
NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndromeSylvie Rusakiewicz, Gaetane Nocturne, Thierry Lazure, et al.Arthritis & Rheumatology (Hoboken, N.J.)|September 16, 2024
Unraveling the Genetics of Shared Clinical and Serological Manifestations in Patients With Systemic Inflammatory Autoimmune DiseasesMatteo Bianchi, Sergey V Kozyrev, Antonella Notarnicola, et al.Arthritis & Rheumatology (Hoboken, N.J.)|June 22, 2022
Strong Association of Combined Genetic Deficiencies in the Classical Complement Pathway With Risk of Systemic Lupus Erythematosus and Primary Sjögren's SyndromeChristian Lundtoft, Christopher Sjöwall, Solbritt Rantapää-Dahlqvist, et al.Proceedings of the National Academy of Sciences of the United States of America|April 7, 2007
Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupusRobert R Graham, Chieko Kyogoku, Snaevar Sigurdsson, et al.Rheumatology (Oxford, England)|September 5, 2020
Genetic and clinical basis for two distinct subtypes of primary Sjögren's syndromeGuðný Ella Thorlacius, Lina Hultin-Rosenberg, Johanna K Sandling, et al.Clinical and Experimental Rheumatology|August 30, 2019
Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patientsSoledad Retamozo, Nihan Acar-Denizli, Astrid Rasmussen, et al.Rheumatology (Oxford, England)|April 6, 2022
Characterization and outcomes of 414 patients with primary SS who developed haematological malignanciesGabriela Hernández-Molina, Belchin Kostov, Pilar Brito-Zerón, et al.Nature Genetics|October 20, 2009
A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosusVesela Gateva, Johanna K Sandling, Geoff Hom, et al.Arthritis & Rheumatology (Hoboken, N.J.)|March 22, 2022
Complement C4 Copy Number Variation is Linked to SSA/Ro and SSB/La Autoantibodies in Systemic Inflammatory Autoimmune DiseasesChristian Lundtoft, Pascal Pucholt, Myriam Martin, et al.Pageof 8